prednisolone has been researched along with Depressive Disorder, Treatment-Resistant in 1 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
Depressive Disorder, Treatment-Resistant: Failure to respond to two or more trials of antidepressant monotherapy or failure to respond to four or more trials of different antidepressant therapies. (Campbell's Psychiatric Dictionary, 9th ed.)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Juruena, MF | 1 |
| Pariante, CM | 1 |
| Papadopoulos, AS | 1 |
| Poon, L | 1 |
| Lightman, S | 1 |
| Cleare, AJ | 1 |
1 trial available for prednisolone and Depressive Disorder, Treatment-Resistant
| Article | Year |
|---|---|
The role of mineralocorticoid receptor function in treatment-resistant depression.
Topics: Canrenone; Case-Control Studies; Depressive Disorder, Treatment-Resistant; Female; Humans; Hydrocort | 2013 |